Last updated: May 29, 2026

Application No. 17/907,697

Synthetic Soluble Receptor Mimics and Methods of Use for Treatment of COVID-19

Non-Final OA

Filed

Sep 29, 2022

Priority

Mar 30, 2020 — provisional 63/001,882 +2 more

Examiner

ROSSI, JULIA ANNE LORRAIN

Art Unit

1615

Tech Center

1600 — Biotechnology & Organic Chemistry

Assignee

The Wistar Institute

OA Round

1 (Non-Final)

This examiner grants 46% of cases after interview

— +60.0% interview lift. A telephonic interview to clarify the technical implementation could significantly improve the outcome.

Based on 28 resolved cases, 2023–2026

Examiner Intelligence

ROSSI, JULIA ANNE LORRAIN View full profile →

Grants 46% of resolved cases

Career Allowance Rate

13 granted / 28 resolved

-13.6% vs TC avg

Strong +60% interview lift

Without

With

+60.0%

Interview Lift

resolved cases with interview

Typical timeline

3y 5m

Avg Prosecution

20 currently pending

Career history

Total Applications

across all art units

Statute-Specific Performance

§101

1.1%

-38.9% vs TC avg

§103

47.4%

+7.4% vs TC avg

§102

8.4%

-31.6% vs TC avg

§112

7.4%

-32.6% vs TC avg

Black line = Tech Center average estimate • Based on career data from 28 resolved cases

Prosecution Timeline

Sep 29, 2022

Application Filed

Sep 12, 2025

Non-Final Rejection mailed

Apr 14, 2026

Response after Non-Final Action

Precedent Cases

Applications granted by this same examiner with similar technology

17/829,302

Patent 12624173

BIODEGRADABLE POLYMERIC COMPOSITIONS, METHODS OF PREPARATION AND USES THEREOF

3y 11m to grant Granted May 12, 2026

17/857,590

Patent 12599561

LOCALIZED IMMUNOSUPPRESSION OF ALLOGRAFTS FOR PERIPHERAL NERVE REPAIR

3y 9m to grant Granted Apr 14, 2026

17/778,394

Patent 12559520

METHOD FOR EXTRACTING A PROTEIN FROM A PRECIPITATE AND METHOD FOR PRECIPITATING IMPURITIES

3y 9m to grant Granted Feb 24, 2026

17/177,236

Patent 12516106

METHOD FOR PROTEIN PURIFICATION

4y 10m to grant Granted Jan 06, 2026

17/762,854

Patent 12486314

FUSION POLYPEPTIDES BINDING ANTIBODY FC DOMAINS AND INTEGRIN AND METHODS OF USE

3y 8m to grant Granted Dec 02, 2025

Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.

Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2

Expected OA Rounds

46%

Grant Probability

99%

With Interview (+60.0%)

3y 5m (~0m remaining)

Median Time to Grant

Low

PTA Risk

Based on 28 resolved cases by this examiner. Grant probability derived from career allowance rate.